Loading…
20,149 Jan Aushadhi Kendras (JAKs) are operational nationwide as of 30 June 2026 under PMBJP, including 690 in Madhya Pradesh (7 in Khandwa) and 43 in Dadra & Nagar Haveli and Daman & Diu.
FY2025-26 sales reached ₹2,252.19 crore, saving citizens an estimated ₹9,000 crore compared to branded-drug prices; district-wise sales data is not maintained by PMBI.
A new partnership has opened 846 JAKs through Primary Agriculture Cooperative Credit Societies (PACS), with over 4,250 PACS given initial approval, extending the scheme's reach into rural cooperative networks.
Affordable generic medicines via dedicated Jan Aushadhi Kendras
Key: Franchise-like model open to individuals, NGOs, societies, trusts and firms; target 25,000 JAKs by March 2027; PACS partnership since 2026 extends reach into rural cooperatives
Implementing agency of PMBJP; manages supply chain, stocking incentives and franchise approvals
Rural cooperative bodies now empanelled to open Jan Aushadhi Kendras, extending the scheme into village-level cooperative networks
NPPA fixes ceiling prices for scheduled medicines under DPCO, underpinning the affordability logic behind PMBJP's generic-drug savings
Lists 384 drugs across 27 therapeutic categories; used as a reference for prioritising essential medicines stocked at JAKs
FDSI supplies free essential medicines at public health facilities, while PMBJP/JAKs sell low-cost generic medicines through retail outlets — together the two schemes cut out-of-pocket drug expenditure through complementary public and retail channels.
GS Paper 2 > Governance > Health & Generic Medicine Schemes
Recurring quarterly Parliament-reply update
National Pharmaceutical Pricing Authority — regulates prices of scheduled/essential medicines under the DPCO, reviewing ceiling prices annually based on the Wholesale Price Index.